Olive extract supplement decreases pain and improves daily activities in adults with osteoarthritis and decreases plasma homocysteine in those with rheumatoid arthritis

Nutrition Research

Volumn 27, Issue 8, 2007, Pages 470-477

  Bitler, Catherine M ^b   Matt, Kathleen ^a   Irving, Mary ^a   Hook, Ginger ^a   Yusen, Joseph ^a   Eagar, Forrest ^a   Kirschner, Ken ^a   Walker, Brian ^a   Crea, Roberto ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b CreAgri Inc   (United States)

Author keywords

Homocysteine; Human intervention; Inflammation; Olive extract; Osteoarthritis

Indexed keywords

HOMOCYSTEINE; OLIVE VEGETATION WATER EXTRACT; PLACEBO; PLANT EXTRACT; POLYPHENOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HEARTBURN; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL SUPPORT; OLIVE; OSTEOARTHRITIS; PAIN; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 34547156540     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2007.06.003     Document Type: Article

References (34)

1. Lawrence R.C., Helmick C.G., Arnett F.C., Deyo R.A., Felson D.T., Giannini E.H., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41 5 (1998) 778-799
2. Chikanza I., and Fernandes L. Novel strategies for the treatment of osteoarthritis. Expert Opin Investig Drugs 9 7 (2000) 1499-1510
3. Brennan F.M., and Feldmann M. Cytokines in autoimmunity. Curr Opin Immunol 4 6 (1992) 754-759
4. Choy E.H., and Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344 12 (2001) 907-916
5. Koolwijk P., Miltenburg A.M., van Erck M.G., Oudshoorn M., Niedbala M.J., Breedveld F.C., et al. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J Rheumatol 22 3 (1995) 385-393
6. Konttinen Y.T., Ainola M., Valleala H., Ma J., Ida H., Mandelin J., et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 58 11 (1999) 691-697
7. Tchetverikov I., Ronday H.K., Van El B., Kiers G.H., Verzijl N., TeKoppele J.M., et al. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis 63 7 (2004) 881-883
8. Mahmoud R.K., El-Ansary A.K., El-Eishi H.H., Kamal H.M., and El-Saeed N.H. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis. Ital J Biochem 54 3-4 (2005) 248-257
9. Skiles J.W., Gonnella N.C., and Jeng A.Y. The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors. Curr Med Chem 11 22 (2004) 2911-2977
10. Linos A., Kaklamani V.G., Kaklamani E., Koumantaki Y., Giziaki E., Papazoglou S., et al. Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables?. Am J Clin Nutr 70 6 (1999) 1077-1082
11. Linos A., Kaklamanis E., Kontomerkos A., Koumantaki Y., Gazi S., Vaiopoulos G., et al. The effect of olive oil and fish consumption on rheumatoid arthritis-a case control study. Scand J Rheumatol 20 6 (1991) 419-426
12. Skoldstam L., Hagfors L., and Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis 62 3 (2003) 208-214
13. Christian M.S., Sharper V.A., Hoberman A.M., Seng J.E., Fu L., Covell D., et al. The toxicity profile of hydrolyzed aqueous olive pulp extract. Drug Chem Toxicol 27 4 (2004) 309-330
14. Bitler C.M., Viale T.M., Damaj B., and Crea R. Hydrolyzed olive vegetation water in mice has anti-inflammatory activity. J Nutr 135 6 (2005) 1475-1479
15. Bruce B., and Fries J.F. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 23 5 Suppl 39 (2005) S14-S18
16. Bruce B., and Fries J.F. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30 1 (2003) 167-178
17. Dyer III J.B., and Crouch J.G. Effects of running and other activities on moods. Percept Mot Skills 67 1 (1988) 43-50
18. van Riel P.L., and Fransen J. DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis. Arthritis Res Ther 7 5 (2005) 189-190
19. Walsh L., Davies P., and McConkey B. Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis. Ann Rheum Dis 38 4 (1979) 362-363
20. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 24 8 (1997) 1477-1485
21. Sandoval D.A., and Matt K.S. Gender differences in the endocrine and metabolic responses to hypoxic exercise. J Appl Physiol 92 2 (2002) 504-512
22. Mohammed F.F., Smookler D.S., and Khokha R. Metalloproteinases, inflammation, and rheumatoid arthritis. Ann Rheum Dis 62 Suppl 2 (2003) ii43-ii47
23. Milner J.M., and Cawston T.E. Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases. Curr Drug Targets Inflamm Allergy 4 3 (2005) 363-375
24. Kosinski M., Zhao S.Z., Dedhiya S., Osterhaus J.T., and Ware Jr. J.E. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 43 7 (2000) 1478-1487
25. Fries J.F., and Ramey D.R. "Arthritis specific" global health analog scales assess "generic" health related quality-of-life in patients with rheumatoid arthritis. J Rheumatol 24 9 (1997) 1697-1702
26. Shacham S., Reinhardt L.C., Raubertas R.F., and Cleeland C.S. Emotional states and pain: intraindividual and interindividual measures of association. J Behav Med 6 4 (1983) 405-419
27. Mallya R.K., deBeer F.C., Berry H., Hamilton E.D., Mace B.E., and Pepys M.B. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 9 2 (1982) 224-228
28. Molenaar E.T., Voskuyl A.E., Familian A., van Mierlo G.J., Dijkmans B.A., and Hack C.E. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein. Arthritis Rheum 44 5 (2001) 997-1002
29. Krogh Jensen M., Ekelund S., and Svendsen L. Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis. Scand J Clin Lab Invest 56 5 (1996) 421-429
30. Landewe R.B., vandenBorne B.E., Breedveld F.C., and Dijkmans B.A. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet 355 9215 (2000) 1616-1617
31. Lazzerini P.E., Capecchi P.L., Bisogno S., Galeazzi M., Marcolongo R., and Pasini F.L. Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. Ann Rheum Dis 62 7 (2003) 694-695
32. Yxfeldt A., Wallberg-Jonsson S., Hultdin J., and Rantapaa-Dahlqvist S. Homocysteine in patients with rheumatoid arthritis in relation to inflammation and B-vitamin treatment. Scand J Rheumatol 32 4 (2003) 205-210
33. Roubenoff R., Dellaripa P., Nadeau M.R., Abad L.W., Muldoon B.A., Selhub J., et al. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 40 4 (1997) 718-722
34. Wallberg-Jonsson S., Cvetkovic J.T., Sundqvist K.G., Lefvert A.K., and Rantapaa-Dahlqvist S. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol 29 5 (2002) 875-882